THS 2.2

OTHER4 trials

Sponsors

Philip Morris Products S.A.

Conditions

Smoking

Unknown Phase

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)

CompletedNCT01959607

Philip Morris Products S.A.Smoking

Start: 2013-07-31End: 2014-04-30Updated: 2025-01-16

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)

CompletedNCT01967732

Philip Morris Products S.A.Smoking

Start: 2013-11-30End: 2014-07-31Updated: 2020-03-17

Evaluation of Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 for 26 Weeks

CompletedNCT02396381

Philip Morris Products S.A.Smoking

Start: 2015-03-12End: 2017-08-01Updated: 2023-01-26

A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2

CompletedNCT02649556

Philip Morris Products S.A.Smoking

Start: 2015-09-30End: 2017-12-20Updated: 2020-12-04

Related Papers

Impact of switching from cigarette smoking to tobacco heating system use on biomarkers of potential harm in a randomized trial

Biomarkers2024-05-2810 citations

Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2)

Nicotine & Tobacco Research2019-05-2353 citations

Evaluation of Biological and Functional Changes in Healthy Smokers Switching to the Tobacco Heating System 2.2 Versus Continued Tobacco Smoking: Protocol for a Randomized, Controlled, Multicenter Study.

2018-08-248 citations